Renal Denervation in the Real World – Practical Guidance for New Users: On-demand

Published: 25 April 2022

  • Views:

    Views Icon 3434
  • Likes:

    Heart Icon 7

Overview

Full programme

Part of

Overview

More from this programme

e-SPACE Cardio-Renal-Metabolic 2022: On-demand

Published: 11 April 2022

  • Views:

    Views Icon 3695
  • Likes:

    Heart Icon 7

Overview

Full programme

Part of

Overview

More from this programme

A Peek into the Future – Repair and Replacement of the Mitral and Tricuspid Valves with the Edwards Portfolio

18

Mar

2021

16:00

GMT

Webinar

Overview


This webinar, at 5pm CET / 4pm GMT, will bring together an internationally-respected faculty to review the PASCAL platform focusing on the recently CE mark approved PASCAL Ace implant system for the treatment of mitral and tricuspid regurgitation.

Through a combination of case presentations, discussion, and a live case procedure from Heidelberg University Hospital, the theory- and practical-based agenda has been formulated to best support everyday practice and enhance patient outcomes.

Pipeline products for tricuspid transcatheter replacement from Edwards Lifesciences will be shown and briefly discussed.

Performed By:

Nicolas M Van Mieghem

Nicolas M Van Mieghem

Peter Lüdike

Peter Lüdike

Philipp Lurz

Philipp Lurz

Ralph Stephan von Bardeleben

Ralph Stephan von Bardeleben

Philip Raake

Philip Raake

Faculty Biographies

Nicolas M Van Mieghem

Nicolas M Van Mieghem

Personal History

From an early age, Professor Nicolas Maria Van Mieghem decided to pursue a career that would help others. “I enjoy the feeling of being able to help someone or do something important for them. I wanted to enter a profession that would channel my energy— I was always a busy child,” he says. 

A budding athlete, he was a member of Belgium’s national swimming team but soon realized that medicine was his true calling. His father was a general cardiologist and one of his biggest influences early in his career.

Professor Van Mieghem initially intended to train as a cardiac surgeon but decided to specialise in interventional cardiology instead, following advice from a mentor. This decision was cemented when he read the first-in-human case report of transcatheter aortic valve implantation (TAVI) in Circulation by Alain Cribier in 2002. 

His mantra is mens sana in corpore sano (a healthy mind in a healthy body). He remains an avid swimmer and cyclist and follows a number of professional sports. “Like all Belgians, I love to watch the big cycling events—the classic cycle races, the Tour de France, the Giro d’Italia, the Vuelta a España,” he says. 

Van Mieghem believes that a great cardiologist genuinely cares for their patients. He names Gary Roubin, Dr Manu Malbrain and Professor Patrick Serruys among his mentors. 


 

Academic History

 

In 2007, Professor Van Mieghem obtained his medical and cardiology degrees at the Catholic University of Leuven, Belgium. He completed fellowships in interventional cardiology in Ziekenhuis Oost-Limburg Genk, Belgium, Lenox Hill Hospital, New York, US and Erasmus Medical Center, Rotterdam, the Netherlands.2 His PhD focused on transcatheter valve therapies.3

His current research focuses on cerebral embolic protection during TAVI and the search for improved large bore closure devices. He works actively in expanding TAVI indications, most notably TAVI as a means to further unload the left ventricle in heart failure patients with moderate aortic stenosis (the TAVR UNLOAD trial). Professor Van Mieghem is also involved in the development and dispersion of mechanical circulatory support (MCS) devices as well as transcatheter mitral and tricuspid repair techniques. In terms of imaging and preprocedural planning, his research has covered computed tomography (CT)-derived 3D modelling and printing.

Professor Van Mieghem has received institutional research grant support from Abbott Vascular, Boston Scientific, Edwards Lifesciences, Medtronic, Daiichi-Sankyo, PulseCath BV and Abiomed.7

 

Career Overview

After his fellowships, Professor Van Mieghem joined the department of interventional cardiology at the Thorax Centre, Erasmus Medical Center, as a senior staff member in February 2010. He is now working there as a Full Professor of Interventional Cardiology.2

As well as his involvement in the percutaneous coronary interventions and structural heart programs, he has published and co-authored over 350 scientific papers in peer-reviewed journals.4 Professor Van Mieghem is a principal investigator and steering committee member in multiple ongoing international trials, evaluating various coronary and transcatheter valve technologies.3 He is a Fellow of the European Society of Cardiology (FESC) and is currently Medical Director of the department of Interventional cardiology at the Thorax Centre.3

 

Career Timeline

  • 2008 - 2009: Fellow, Interventional Cardiology, Lenox Hill Hospital
  • 2010: Joined the senior staff, Interventional Cardiology, Thorax Centre, Erasmus MC
  • 2014: Clinical Director, Interventional Cardiology, Erasmus MC
  • 2019 - Present: Full Professor, Interventional Cardiology, Erasmus MC
  • Present: Medical Director, Interventional Cardiology, Thorax Centre 

 

Areas of Speciality4

  • Interventional Cardiology
  • Transcatheter Heart Valve Interventions

 

Sources

  1. https://cardiovascularnews.com/nicolas-van-mieghem/
  2. https://esc365.escardio.org/Person/418700-dr-van-mieghem-nicolas 
  3. https://www.radcliffecardiology.com/authors/nicolas-m-van-mieghem 
  4. https://www.ecri-trials.com/faculty/nicolas-van-mieghem/ 
  5. https://www.cardialysis.com/core-lab/supervising-cardiologists/ 
  6. https://www.worldcat.org/title/transcatheter-aortic-valve-therapies-from-cutting-edge-to-mainstream-catheter-gebonden-aortaklep-implantatie/oclc/892053833 
  7. https://www.jacc.org/doi/pdf/10.1016/j.jcin.2020.12.021 

 

 Prof Van Mieghem is on the ICR3 Editorial Board.

 

View full profile
Peter Lüdike

Peter Lüdike

Prof Peter Lüdike is Senior Physician of the Heart Failure and Intensive Care section in the Department of Cardiology and Vascular Medicine at the West German Heart and Vascular Center, University Hospital Essen. He achieved Venia legendi for internal medicine in 2018 and was appointed as Full Professor for heart failure in 2020. His research interests include intensive care medicine, emergency medicine, heart failure, mitral valve disease and the role of macrophage migration inhibitory factor in the development of ischaemic heart disease.

View full profile
Philipp Lurz

Philipp Lurz

Prof Philipp Lurz is Deputy Head of the Department at Heart Center Leipzig, Germany, a position he has held since 2018. Previously, Prof Lurz was a Clinical Research Fellow at Great Ormond Street Hospital for Children NHS Foundation Trust. He completed his education at the University of Leipzig, and is a member of the German Society of Cardiology. Prof Lurz is widely published in leading international peer-reviewed journals.

View full profile
Ralph Stephan von Bardeleben

Ralph Stephan von Bardeleben

Dr Ralph Stephan von Bardeleben is the Head of the Center of Structural Heart Disease Interventions and the Heart Valve Center in Mainz, Germany. Following the completion of his medical education at the University of Mainz and the University of California in San Francisco, US, Dr Bardeleben trained as both an imager and interventional cardiologist. Since 2004 he has served as Head of the CV imaging department. A regular speaker at international events, Dr Bardeleben's department has played key roles in a number of early 'in-man' implantations and other international trials.

View full profile
Philip Raake

Philip Raake

Prof Philip Raake is a senior physician who leads the HFU centre at the Department of Cardiology at Heidelberg University Hospital. He also runs the Interventional HF programme.

Prof Philip Raake attended medical school at the Ludwig-Maximilians University in Munich. Between 2006 and 2008, Prof Raake worked at the Center for Translational Medicine, under the direction of Prof Walter Koch, at the Thomas Jefferson University, Philadelphia.

In 2008 Prof Raake returned to Germany, where his established the first university Advanced Heart Failure Unit in Germany focusing on optimised care in advanced HF. He has authored or co-authored several papers in leading peer-reviewed journals on HF basic molecular mechanisms, and clinical aspects of advanced HF. He serves on several working groups for the German Society for Cardiology and the German Federal Physicians Association.

View full profile

The Key to the Castle: Revolutionizing Transseptal Access for Structural Heart Procedures

16

Feb

2022

16:00

GMT

Webinar

Overview

Transseptal puncture (TSP) plays an increasingly significant role in left sided structural heart procedures. Often underestimated, operators might run into difficulties, especially in presence of complex septal anatomies (e.g. fibrotic, floppy septum, plugs etc.).

Learn from an expert panel as they discuss the evolution of left heart access and the techniques and tools they’ve implemented to improve procedural efficiency and optimize patient outcomes. Through illustrative case examples and lively panel discussion, experts will share their step-by-step clinical workflows and latest tools for efficient and precise transseptal puncture, tips for overcoming challenging scenarios, and novel approaches to structural heart procedures with reduced use of fluoroscopy.

 

 

PRM-00870

Performed By:

Ole De Backer

Ole De Backer

Sagar Doshi

Sagar Doshi

Christoph Hammerstingl

Christoph Hammerstingl

Adnan Nadir

Adnan Nadir

Faculty Biographies

Ole De Backer

Ole De Backer

Prof Dr Ole De Backer is an internationally renowned interventional cardiologist working at Rigshospitalet, Copenhagen University Hospital, Denmark and is an expert in structural heart interventions – among others transcatheter heart valve interventions, percutaneous left atrial appendage closure and thoracic endovascular aortic repair. Special areas of interest are the development and adoption of a fully percutaneous, minimal invasive approach for different structural heart interventions and the use of advanced cardiac imaging tools for planning and guidance of these interventions. He is actively involved and leading several research projects in the field of transcatheter heart valves and percutaneous left atrial appendage closure. 

View full profile
Sagar Doshi

Sagar Doshi

Dr Sagar Doshi is Director of the TAVI program at the Queen Elizabeth Hospital in Birmingham where he was appointed to a consultant post in 2005. He was awarded a British Heart Foundation Junior Research Fellowship and undertook his MD at the Wales Heart Research Institute. He was awarded a scholarship to undertake an Interventional Cardiology Fellowship at the prestigious Mount Sinai Hospital, New York, USA.  He has proctored TAVI cases in the UK, Japan and the USA. He has over 70 scientific publications and is an Honorary Senior lecturer at Birmingham Medical School.

View full profile
Christoph Hammerstingl

Christoph Hammerstingl

Prof Dr Christoph Hammerstingl is head of the department of Internal Medicine and Cardiology at the Eduardus Hospital in Cologne. He started his career at the University Hospital in Bonn, where he established interventional echocardiography since 2010 for the treatment of mitral and tricuspid valve disease. As an interventionalist he proctored structural cases all over Europe and North America. He has over 150 scientific publications focussed on the outcomes of minimal invasive therapies of the AV valves, interventional and medical strategies for stroke prevention.

View full profile
Adnan Nadir

Adnan Nadir

Dr Adnan Nadir is a consultant in interventional cardiology. He is an expert on structural heart disease interventions with a focus on transcatheter heart valve interventions. He graduated with top honours from medical school and completed his extensive medical training across three continents. He undertook advanced interventional cardiology and structural heart disease fellowships in the UK and the USA before his appointment at Queen Elizabeth Hospital, Birmingham UK. Dr. Nadir firmly believes in a patient-centered approach and practices shared-decision making to give his patients the confidence in treatment options available to them. In his free time, he is kept busy by his young family and permaculture gardening while (occasionally) indulging in cycling, landscape photography, and skiing. 

View full profile

SGLT-2 Inhibitors and Cardio-renal Outcomes: Translating the Data into Practice

Published: 12 November 2021

  • Views:

    Views Icon 13060
  • Likes:

    Heart Icon 7

Overview

Full programme

Part of

Overview

More from this programme

SGLT-2 Inhibitors in Heart Failure: Putting the Evidence Into Practice

Published: 27 August 2021

  • Views:

    Views Icon 8023
  • Likes:

    Heart Icon 7

Overview

Full programme

Part of

Overview

More from this programme

Coronary Bifurcations PCI

Published: 11 June 2021

  • Views:

    Views Icon 822
  • Likes:

    Heart Icon 7

Overview

Full programme

Part of

Overview

More from this programme

EuroPCR 2021 Wrap-up: Mitral and Tricuspid Therapies

Published: 20 May 2021

  • Views:

    Views Icon 11141
  • Likes:

    Heart Icon 7

Overview

Full programme

Part of

Overview

More from this programme

Optimising Treatment of HF

Published: 21 April 2021

  • Views:

    Views Icon 18407
  • Likes:

    Heart Icon 7

Overview

Full programme

Part of

Overview

More from this programme

Video

TCT Connect 2020 Discussion: The FORECAST Trial

Published: 21 Oct 2020

  • Views:

    Views Icon 354
  • Likes:

    Heart Icon 0

Dr Mirvat Alasnag (The King Fahd Armed Forces Hospital, Jeddah, KSA) and Prof Nick Curzen (University Hospital Southampton NHS Trust, Southampton, UK) discuss the design, outcomes, economic implications of the FORECAST late-breaking trial. 

Recorded remotely from Jeddah and Southampton, 2020. 

Recording Editors: Natascha Wienand, Tom Green
Editor: Mirjam Boros

Subscribe to